ImmunityBio COVID-19 vaccine (2nd generation adenovirus platform)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ImmunityBio COVID-19 vaccine (2nd generation adenovirus platform), covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA [Phase 1]